(Q30234777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

2 references

13 July 2022

22 October 2022

Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

Middle East respiratory syndrome coronavirus

17 March 2020

main subject

0 references

0 references

1 reference

Middle East respiratory syndrome

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Bart L. Haagmans

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

V Stalin Raj

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

13 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

Current opinion in virology

17 March 2020

1 April 2017

2 references

13 July 2022

22 October 2022

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

13 July 2022

22 October 2022

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

49-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28412285%20AND%20SRC:MED&resulttype=core&format=json

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.

17 March 2020

cites work

1 reference

12 December 2020

Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice

1 reference

12 December 2020

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

1 reference

12 December 2020

Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design

1 reference

12 December 2020

Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014.

1 reference

12 December 2020

3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012

1 reference

12 December 2020

A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

1 reference

12 December 2020

The Immunobiology of SARS*.

1 reference

12 December 2020

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

12 December 2020

Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice

1 reference

12 December 2020

A Comparative Review of Animal Models of Middle East Respiratory Syndrome Coronavirus Infection.

1 reference

12 December 2020

T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice

1 reference

12 December 2020

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis.

1 reference

12 December 2020

T cell-mediated immune response to respiratory coronaviruses

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

1 reference

12 December 2020

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

1 reference

12 December 2020

Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study

1 reference

12 December 2020

One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus

1 reference

12 December 2020

Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection

1 reference

12 December 2020

Unraveling the drivers of MERS-CoV transmission

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

1 reference

12 December 2020

Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies

1 reference

12 December 2020

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

1 reference

12 December 2020

Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection

1 reference

12 December 2020

MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques

1 reference

12 December 2020

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

1 reference

12 December 2020

Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants

1 reference

12 December 2020

Transmission of MERS-coronavirus in household contacts

1 reference

12 December 2020

Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014.

1 reference

12 December 2020

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

12 December 2020

Animal models of Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection

1 reference

12 December 2020

1 reference

12 December 2020

Evaluation of candidate vaccine approaches for MERS-CoV.

1 reference

12 December 2020

Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses

1 reference

12 December 2020

Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia

1 reference

12 December 2020

Mortality Risk Factors for Middle East Respiratory Syndrome Outbreak, South Korea, 2015.

1 reference

12 December 2020

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

1 reference

12 December 2020

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection

1 reference

12 December 2020

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.

1 reference

12 December 2020

Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

1 reference

12 December 2020

Exacerbated innate host response to SARS-CoV in aged non-human primates

1 reference

12 December 2020

Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus.

1 reference

12 December 2020

Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.

1 reference

12 December 2020

Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015.

1 reference

12 December 2020

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

1 reference

12 December 2020

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

1 reference

12 December 2020

The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents

1 reference

12 December 2020

Vaccine initiative marks bold resolution

1 reference

12 December 2020

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

1 reference

12 December 2020

An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014.

1 reference

12 December 2020

Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness

1 reference

12 December 2020

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

1 reference

12 December 2020

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection

1 reference

12 December 2020

Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection

1 reference

12 December 2020

SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement

1 reference

12 December 2020

Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus

1 reference

12 December 2020

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

1 reference

12 December 2020

Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice

1 reference

12 December 2020

A mouse model for MERS coronavirus-induced acute respiratory distress syndrome

1 reference

12 December 2020

Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies

1 reference

12 December 2020

Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study

1 reference

12 December 2020

Rapid generation of a mouse model for Middle East respiratory syndrome

1 reference

12 December 2020

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

1 reference

12 December 2020

Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.

1 reference

12 December 2020

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection

1 reference

12 December 2020

Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia

1 reference

12 December 2020

Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge

1 reference

12 December 2020

Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus

1 reference

12 December 2020

Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel

1 reference

12 December 2020

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines

1 reference

12 December 2020

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

1 reference

12 December 2020

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea

1 reference

12 December 2020

Vaccines for the elderly.

1 reference

12 December 2020